HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of June 30, 2024: Q2 2024
Type / Class: Debt / NOTE 1.000% 8/1
Principal, excl. options Q2 2024: 24B
Holdings value Q2 2024: $700M
Value change Q2 2024: -$19.9M
Grand Portfolio weight change Q2 2024: 0%
Number of holders: 70
Number of buys Q2 2024: 4
Number of sells Q2 2024: -10
Average buys Q2 2024 %: +0%
Average sells Q2 2024 %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Principal	Value	Change	Price	Investors
2024 Q3	$123M	$148M	-$65.2M	$1.19	16
2024 Q2	$24B	$700M	-$19.9M	$1.11	71
2024 Q1	$623M	$607M	-$28.9M	$0.97	69
2023 Q4	$658M	$615M	+$10.1M	$0.93	70
2023 Q3	$644M	$608M	+$606M	$0.94	62